Lintaz 1.125gm injection

AXIFUR-H 1.5G

Price 68.4 INR / Piece

Minimum Order Quantity : 50 Pieces

Quantity : 1.5g

Ingredients : Cefuroxime and Sulbactam Injection

Dosage Guidelines : Intravenous or intramuscular use only as prescribed

Drug Type : Other, Allopathic

CEFTRAX 250MG INJECTION

Price 27.0 INR / Box

Minimum Order Quantity : 50 Pieces

Quantity : 50 Pieces

Ingredients : Brand Name: CEFTRAX 250 mg Generic Name / Content: Ceftriaxone Injection I.P. 250 mg Company: Aurobindo Pharma Lt CEFTRAX 250 mg Injection contains Ceftriaxone, a thirdgeneration cephalosporin antibiotic used to treat a wide range of bacterial infections. It works by inhibiting bacterial cell wall synthesis, resulting in the death of susceptible bacteria. This sterile injectable formulation is intended for intravenous (IV) or intramuscular (IM) administration in hospital and clinical settings. Indications Respiratory tract infections (pneumonia, bronchitis, sinusitis) Urinary tract infections (UTIs) Skin and soft tissue infections Bone and joint infections Septicemia and bacteremia Meningitis Gonorrhea and other sexually transmitted infections Surgical prophylaxis Key Features Thirdgeneration cephalosporin antibiotic Broadspectrum activity against Grampositive and Gramnegative bacteria Rapid and effective action Sterile injectable form suitable for IV or IM use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial / Ampoule) Category: Injectable / Parenteral Antibiotic Strength: 250 mg per vial Content: Ceftriaxone I.P. Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Dosage Guidelines : As Per Suggestion

Drug Type : Injection

CEFTRAX TZ 1.125

Price 242.0 INR / Vial

Minimum Order Quantity : 50 Vials

Quantity : 50 Pieces

Ingredients : Brand Name: CEFTRAX 1.125 TZ Generic Name / Content: Ceftriaxone + Tazobactam Injection I.P. 1.125 g Company: Aurobindo Pharma Ltd CEFTRAX 1.125 TZ Injection is a combination antibiotic containing Ceftriaxone (a thirdgeneration cephalosporin) and Tazobactam (a betalactamase inhibitor). This dualaction formulation provides broadspectrum antibacterial activity, including efficacy against betalactamase producing bacteria. Ceftriaxone inhibits bacterial cell wall synthesis, while Tazobactam prevents enzymatic degradation of the antibiotic, enhancing overall effectiveness. This sterile injectable formulation is suitable for intravenous (IV) or intramuscular (IM) administration in hospitals and clinical settings. Indications Severe respiratory tract infections (pneumonia, bronchitis, sinusitis) Urinary tract infections (UTIs) Skin and soft tissue infections Bone and joint infections Intraabdominal infections Septicemia and bacteremia Gynecological infections Surgical prophylaxis Key Features Thirdgeneration cephalosporin combined with a betalactamase inhibitor Broadspectrum antibacterial coverage Effective against resistant bacterial strains Sterile injectable formulation for IV or IM use Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Injection (Vial) Category: Injectable / Parenteral Antibiotic Strength: 1.125 g per vial Content: Ceftriaxone + Tazobactam Packaging & Storage Supplied in sterile vial packaging Store in a cool, dry place below 25 C Protect from light Use under qualified medical supervision

Dosage Guidelines : As Per Suggestion

Drug Type : Injection

LIN + VE TAB 600MG

Price 354.0 INR / Box

Minimum Order Quantity : 50 Boxes

Quantity : 50 Boxes

Ingredients : Brand Name: LIN+IV 600 mg Tablet Generic Name / Content: Linezolid Tablet I.P. 600 mg Company: Aurobindo Pharma Ltd LIN+IV 600 mg Tablet contains Linezolid, a synthetic oxazolidinoneclass antibiotic used for the treatment of serious Grampositive bacterial infections. It works by inhibiting bacterial protein synthesis, effectively stopping the growth and multiplication of susceptible bacteria. This oral formulation is suitable for patients requiring outpatient therapy or for hospital use when intravenous therapy is not needed. Indications Complicated skin and soft tissue infections Communityacquired pneumonia (CAP) Hospitalacquired pneumonia (HAP) Infections caused by methicillinresistant Staphylococcus aureus (MRSA) Vancomycinresistant Enterococcus faecium (VRE) infections Key Features Oxazolidinoneclass broadspectrum antibiotic Effective against multidrugresistant Grampositive bacteria Oral tablet formulation for easy administration Rapid onset of action Manufactured by Aurobindo Pharma Ltd Dosage Form & Category Dosage Form: Tablet Category: Oral Antibiotic (Oxazolidinone Class) Strength: 600 mg Content: Linezolid I.P. Packaging & Storage Supplied in blister packs or bottles as per packaging Store in a cool, dry place below 25 C Protect from light and moisture Use under qualified medical supervision